Mucosal Immunity and IgA Responses

Core Idea

Mucosal surfaces (gut, respiratory, genital) are protected by organized lymphoid tissues (gut-associated lymphoid tissue, GALT; nasopharyngeal-associated lymphoid tissue) and by secreted IgA produced by plasma cells in mucosal lamina propria and shipped via polymeric immunoglobulin receptor. Dimeric IgA transcytoses across epithelium where SC (secretory component) protects it from degradation. IgA prevents pathogen translocation and toxin binding without triggering inflammation. Commensal bacteria shape mucosal immune tolerance through interactions with dendritic cells and T regulatory cells.

How It's Best Learned

Diagram the mucosal immune system from antigen capture via M cells to IgA plasma cell generation. Compare mucosal (IgA-dominated) with systemic (IgG-dominated) immunity.

Common Misconceptions

• Mucosal immunity is identical to systemic immunity (mucosal sites induce distinct Th2-biased responses, IgA switching, and tissue-resident memory cells). - IgA functions through complement activation (IgA is poor at complement activation; it functions mainly through exclusion and immune exclusion).

Explainer

From antibody isotypes and effector functions, you know that the immune system produces different classes of antibody — IgG, IgM, IgA, IgE, IgD — each with distinct roles. From your understanding of the digestive system, you know that mucosal surfaces are vast, thin barriers constantly exposed to the outside world. The gut alone has a surface area of roughly 32 square meters, and the respiratory tract adds more. These surfaces face a unique immunological challenge: they must defend against pathogens while tolerating food antigens and the trillions of commensal bacteria that are essential for health. Mucosal immunity is a specialized branch of the immune system evolved to meet this challenge, and its signature weapon is secretory IgA.

Mucosal surfaces are patrolled by organized lymphoid structures collectively known as mucosa-associated lymphoid tissue (MALT). In the gut, this includes Peyer's patches, isolated lymphoid follicles, and the mesenteric lymph nodes — together called GALT (gut-associated lymphoid tissue). The sampling process begins with M cells, specialized epithelial cells that overlie Peyer's patches and actively transport antigens from the gut lumen to underlying dendritic cells and lymphocytes. Dendritic cells process these antigens and present them to T cells, which in turn help B cells undergo class switching to IgA — driven by the cytokines TGF-β and the mucosal environment itself. The resulting IgA-producing plasma cells migrate to the lamina propria, the connective tissue layer just beneath the epithelium, where they secrete large quantities of dimeric IgA — two IgA molecules joined by a J chain.

Getting this dimeric IgA from the lamina propria into the gut lumen requires a dedicated transport system. Epithelial cells on their basolateral surface express the polymeric immunoglobulin receptor (pIgR), which binds dimeric IgA and carries it through the cell by transcytosis. At the apical (luminal) surface, the receptor is cleaved, releasing the IgA with a piece of the receptor still attached — this remnant is the secretory component (SC), and it protects the IgA molecule from degradation by the harsh proteases and low pH of the gut lumen. The resulting secretory IgA (sIgA) is the most abundantly produced antibody in the human body — roughly 3 to 5 grams per day.

Secretory IgA works primarily through immune exclusion — a non-inflammatory mechanism fundamentally different from how IgG operates in the blood. Rather than activating complement or recruiting phagocytes (which would damage the delicate mucosal epithelium), sIgA coats pathogens and toxins, preventing them from binding to and crossing the epithelial barrier. It neutralizes viruses before they can infect epithelial cells, agglutinates bacteria to prevent colonization, and blocks toxins from reaching their receptors. This "quiet" defense is critical: an inflammatory response at a mucosal surface — with complement activation, neutrophil recruitment, and tissue damage — would compromise the barrier it is trying to protect. The mucosal immune system also actively maintains tolerance to commensal bacteria through interactions between mucosal dendritic cells and regulatory T cells, ensuring that the immune response is calibrated to eliminate threats without attacking the beneficial microbiota that the body depends on.